The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Plasma Derivatives-Global Market Insights and Sales Trends 2025
Synopsis
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The global Blood Plasma Derivatives market size is expected to reach US$ 47030 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma Derivatives in various end use industries. The expanding demands from the Hospitals, Clinics and Other End Users,, are propelling Blood Plasma Derivatives market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Factor VIII segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma Derivatives covered in this report include Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG and CSL Limited, etc.
The global Blood Plasma Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
SK Plasma
Fusion Health Care
Biotest AG
Green Cross Corporation
Baxter International
LFB
Octapharma AG
CSL Limited
Takeda
China Biologic Products
Kedrion Biopharma
BDI Pharma
Bayer AG
Hualan Biological Engineering
Global Blood Plasma Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma Derivatives market, Segment by Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Global Blood Plasma Derivatives market, by Application
Hospitals
Clinics
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Plasma Derivatives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The global Blood Plasma Derivatives market size is expected to reach US$ 47030 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma Derivatives in various end use industries. The expanding demands from the Hospitals, Clinics and Other End Users,, are propelling Blood Plasma Derivatives market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Factor VIII segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma Derivatives covered in this report include Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG and CSL Limited, etc.
The global Blood Plasma Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
SK Plasma
Fusion Health Care
Biotest AG
Green Cross Corporation
Baxter International
LFB
Octapharma AG
CSL Limited
Takeda
China Biologic Products
Kedrion Biopharma
BDI Pharma
Bayer AG
Hualan Biological Engineering
Global Blood Plasma Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma Derivatives market, Segment by Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Global Blood Plasma Derivatives market, by Application
Hospitals
Clinics
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Plasma Derivatives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Blood Plasma Derivatives
1.1 Blood Plasma Derivatives Market Overview
1.1.1 Blood Plasma Derivatives Product Scope
1.1.2 Blood Plasma Derivatives Market Status and Outlook
1.2 Global Blood Plasma Derivatives Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Blood Plasma Derivatives Market Size by Region (2018-2029)
1.4 Global Blood Plasma Derivatives Historic Market Size by Region (2018-2023)
1.5 Global Blood Plasma Derivatives Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Blood Plasma Derivatives Market Size (2018-2029)
1.6.1 North America Blood Plasma Derivatives Market Size (2018-2029)
1.6.2 Europe Blood Plasma Derivatives Market Size (2018-2029)
1.6.3 Asia-Pacific Blood Plasma Derivatives Market Size (2018-2029)
1.6.4 Latin America Blood Plasma Derivatives Market Size (2018-2029)
1.6.5 Middle East & Africa Blood Plasma Derivatives Market Size (2018-2029)
2 Blood Plasma Derivatives Market by Type
2.1 Introduction
2.1.1 Albumin
2.1.2 Factor VIII
2.1.3 Factor IX
2.1.4 Immunoglobulin
2.1.5 Hyperimmune Globulin
2.1.6 Others
2.2 Global Blood Plasma Derivatives Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Blood Plasma Derivatives Historic Market Size by Type (2018-2023)
2.2.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Blood Plasma Derivatives Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Blood Plasma Derivatives Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Blood Plasma Derivatives Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Blood Plasma Derivatives Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Blood Plasma Derivatives Revenue Breakdown by Type (2018-2029)
3 Blood Plasma Derivatives Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other End Users
3.2 Global Blood Plasma Derivatives Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Blood Plasma Derivatives Historic Market Size by Application (2018-2023)
3.2.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Blood Plasma Derivatives Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Blood Plasma Derivatives Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Blood Plasma Derivatives Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Blood Plasma Derivatives Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Blood Plasma Derivatives Revenue Breakdown by Application (2018-2029)
4 Blood Plasma Derivatives Competition Analysis by Players
4.1 Global Blood Plasma Derivatives Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2022)
4.3 Date of Key Players Enter into Blood Plasma Derivatives Market
4.4 Global Top Players Blood Plasma Derivatives Headquarters and Area Served
4.5 Key Players Blood Plasma Derivatives Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Plasma Derivatives Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Blood Plasma Derivatives Products, Services and Solutions
5.1.4 Grifols Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.1.5 Grifols Recent Developments
5.2 SK Plasma
5.2.1 SK Plasma Profile
5.2.2 SK Plasma Main Business
5.2.3 SK Plasma Blood Plasma Derivatives Products, Services and Solutions
5.2.4 SK Plasma Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.2.5 SK Plasma Recent Developments
5.3 Fusion Health Care
5.3.1 Fusion Health Care Profile
5.3.2 Fusion Health Care Main Business
5.3.3 Fusion Health Care Blood Plasma Derivatives Products, Services and Solutions
5.3.4 Fusion Health Care Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.3.5 Biotest AG Recent Developments
5.4 Biotest AG
5.4.1 Biotest AG Profile
5.4.2 Biotest AG Main Business
5.4.3 Biotest AG Blood Plasma Derivatives Products, Services and Solutions
5.4.4 Biotest AG Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.4.5 Biotest AG Recent Developments
5.5 Green Cross Corporation
5.5.1 Green Cross Corporation Profile
5.5.2 Green Cross Corporation Main Business
5.5.3 Green Cross Corporation Blood Plasma Derivatives Products, Services and Solutions
5.5.4 Green Cross Corporation Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.5.5 Green Cross Corporation Recent Developments
5.6 Baxter International
5.6.1 Baxter International Profile
5.6.2 Baxter International Main Business
5.6.3 Baxter International Blood Plasma Derivatives Products, Services and Solutions
5.6.4 Baxter International Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.6.5 Baxter International Recent Developments
5.7 LFB
5.7.1 LFB Profile
5.7.2 LFB Main Business
5.7.3 LFB Blood Plasma Derivatives Products, Services and Solutions
5.7.4 LFB Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.7.5 LFB Recent Developments
5.8 Octapharma AG
5.8.1 Octapharma AG Profile
5.8.2 Octapharma AG Main Business
5.8.3 Octapharma AG Blood Plasma Derivatives Products, Services and Solutions
5.8.4 Octapharma AG Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.8.5 Octapharma AG Recent Developments
5.9 CSL Limited
5.9.1 CSL Limited Profile
5.9.2 CSL Limited Main Business
5.9.3 CSL Limited Blood Plasma Derivatives Products, Services and Solutions
5.9.4 CSL Limited Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.9.5 CSL Limited Recent Developments
5.10 Takeda
5.10.1 Takeda Profile
5.10.2 Takeda Main Business
5.10.3 Takeda Blood Plasma Derivatives Products, Services and Solutions
5.10.4 Takeda Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.10.5 Takeda Recent Developments
5.11 China Biologic Products
5.11.1 China Biologic Products Profile
5.11.2 China Biologic Products Main Business
5.11.3 China Biologic Products Blood Plasma Derivatives Products, Services and Solutions
5.11.4 China Biologic Products Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.11.5 China Biologic Products Recent Developments
5.12 Kedrion Biopharma
5.12.1 Kedrion Biopharma Profile
5.12.2 Kedrion Biopharma Main Business
5.12.3 Kedrion Biopharma Blood Plasma Derivatives Products, Services and Solutions
5.12.4 Kedrion Biopharma Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.12.5 Kedrion Biopharma Recent Developments
5.13 BDI Pharma
5.13.1 BDI Pharma Profile
5.13.2 BDI Pharma Main Business
5.13.3 BDI Pharma Blood Plasma Derivatives Products, Services and Solutions
5.13.4 BDI Pharma Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.13.5 BDI Pharma Recent Developments
5.14 Bayer AG
5.14.1 Bayer AG Profile
5.14.2 Bayer AG Main Business
5.14.3 Bayer AG Blood Plasma Derivatives Products, Services and Solutions
5.14.4 Bayer AG Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.14.5 Bayer AG Recent Developments
5.15 Hualan Biological Engineering
5.15.1 Hualan Biological Engineering Profile
5.15.2 Hualan Biological Engineering Main Business
5.15.3 Hualan Biological Engineering Blood Plasma Derivatives Products, Services and Solutions
5.15.4 Hualan Biological Engineering Blood Plasma Derivatives Revenue (US$ Million) & (2018-2023)
5.15.5 Hualan Biological Engineering Recent Developments
6 North America
6.1 North America Blood Plasma Derivatives Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Plasma Derivatives Market Dynamics
11.1 Blood Plasma Derivatives Industry Trends
11.2 Blood Plasma Derivatives Market Drivers
11.3 Blood Plasma Derivatives Market Challenges
11.4 Blood Plasma Derivatives Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
